| Product Code: ETC12942606 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 India mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 India mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 India mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases that can be targeted by mRNA therapeutics in India |
4.2.2 Growing investment in research and development of mRNA therapeutics in the country |
4.2.3 Favorable government initiatives and policies supporting the development of mRNA therapeutics in India |
4.3 Market Restraints |
4.3.1 High costs associated with mRNA therapeutics research and development |
4.3.2 Lack of skilled workforce and expertise in mRNA therapeutics manufacturing |
4.3.3 Stringent regulatory requirements and approval processes for mRNA therapeutics in India |
5 India mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 India mRNA Therapeutics Contract Development Manufacturing Market, By Types |
6.1 India mRNA Therapeutics Contract Development Manufacturing Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Process Development, 2021 - 2031F |
6.1.4 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.5 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.1.6 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Formulation Development, 2021 - 2031F |
6.1.7 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Regulatory Support, 2021 - 2031F |
6.2 India mRNA Therapeutics Contract Development Manufacturing Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2.3 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Therapeutics, 2021 - 2031F |
6.2.4 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031F |
6.2.5 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.6 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.3 India mRNA Therapeutics Contract Development Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.3.4 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.3.5 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.6 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.4 India mRNA Therapeutics Contract Development Manufacturing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.4.4 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Contract Manufacturing Organizations, 2021 - 2031F |
6.4.5 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Clinical Research Organizations, 2021 - 2031F |
6.5 India mRNA Therapeutics Contract Development Manufacturing Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Lipid Nanoparticles, 2021 - 2031F |
6.5.3 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By In Vitro Transcription, 2021 - 2031F |
6.5.4 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Encapsulation Methods, 2021 - 2031F |
6.5.5 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By CRISPR Technology, 2021 - 2031F |
6.5.6 India mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By AI-Based Quality Control, 2021 - 2031F |
7 India mRNA Therapeutics Contract Development Manufacturing Market Import-Export Trade Statistics |
7.1 India mRNA Therapeutics Contract Development Manufacturing Market Export to Major Countries |
7.2 India mRNA Therapeutics Contract Development Manufacturing Market Imports from Major Countries |
8 India mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
8.1 Number of clinical trials involving mRNA therapeutics conducted in India |
8.2 Percentage increase in research funding allocated to mRNA therapeutics in the country |
8.3 Number of partnerships and collaborations between Indian companies and global players in mRNA therapeutics sector |
9 India mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
9.1 India mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 India mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 India mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 India mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 India mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
10.1 India mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 India mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here